Mechanisms and Treatment of Diabetic Complications

OR28-1

Inhibition of miR29a Restores Post Ischemic Angiogenesis in Hyperglycemia
Lingdan Chen, Dawit Ayalew, Lyeda Shahid, Danny Wang and Ayotunde O Dokun

OR28-2

Sildenafil Preserved Renal Function in Mice with Diabetic Nephropathy
Riccardo Pofi, Mary A. Venneri, Daniela Fiore, Giuseppe Panio, Rita De Gaetano, Carlotta Pozza, Daniele Gianfrilli, Carmine Nicoletti, Fabio Naro, Andrea Lenzi and Andrea M Isidori

OR28-3

Exenatide Suppresses TGFβ1: A Novel Potential Role for GLP-1 Agonists in Nephropathy
Husam Ghanim, Ajay Chaudhuri, Sanaa Abuaysheh, Kelly Green, Antoine Makdissi and Paresh Dandona

OR28-4

Circulating microRNA Profiling in Patients Protected Against Diabetic Nephropathy Despite More Than 40 Years Duration Type 1 Diabetes
Eiichiro Satake, Stephanie Croall, Adam Smiles, Andrzej S Krolewski and Marcus G Pezzolesi

OR28-5

The Association of Admission Hyperglycemia and Adverse Clinical Outcome in Medical Emergency Patients Depends on Diabetic Status Results from the Multi-National, Prospective, Observational Triage Study
Alexander Kutz, Tristan Mirko Struja, Pierre Hausfater, Devendra N. Amin, Sebastian Haubitz, Beat Mueller, Andreas Huber and Philipp Schuetz

OR28-6

Dapagliflozin: Metabolic and Molecular Mechanisms of Increased Plasma Ketones
Carolina Solis-Herrera, Guiseppe Daniele, Devjit Tripathy, Aurora Merovci, Luke Norton, Muhammad Abdul-Ghani and Ralph DeFronzo